FindTrial
Sign In

Expectative management

OTHER3 trials

Sponsors

Radboud University Medical Center, Catharina Ziekenhuis Eindhoven, Radboud Universitair Medisch Centrum

Conditions

CIN 2/3Cervical High Grade Squamous Intraepithelial LesionCervical Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 2/3Patent Ductus ArteriosusPatent ductus arteriosus

Unknown Phase

Early Treatment Versus Expectative Management of PDA in Preterm Infants
CompletedNCT02884219
Radboud University Medical CenterPatent Ductus Arteriosus
Start: 2016-12-23End: 2022-03-15Updated: 2023-07-03
Multi-center, randomized non-inferiority trial of early treatment versus expectative management of patent ductus arteriosus in preterm infants.
Active, not recruitingNL-OMON47250
Radboud Universitair Medisch CentrumPatent ductus arteriosus
Start: 2016-12-23Target: 435Updated: 2024-02-28
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
RecruitingNCT05405270
Catharina Ziekenhuis EindhovenCervical High Grade Squamous Intraepithelial Lesion, Cervical Intraepithelial Neoplasia, Cervical Intraepithelial Neoplasia Grade 2/3 +1
Start: 2022-06-01End: 2026-12-31Target: 410Updated: 2023-09-11

Related Papers

Long-Term Outcomes of Expectant Management versus Early Ibuprofen for Patent Ductus Arteriosus: 24-Month Follow-Up of the BeNeDuctus Trial.
2026-09-17
Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus
New England Journal of Medicine2022-12-06164 citations
Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan
Trials2021-09-1515 citations
Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).
2018-08-0450 citations